Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Irritable Colon, Irritable Bowel Syndrome (IBS)

In brief

This is a three-period crossover study to compare GW876008 and placebo to see if GW876008 will normalise blood flow responses after different emotional stimuli.

Key facts

Study ID
NCT00376896
Run by
GlaxoSmithKline
People needed
25
Starts
2006-11-01
Expected to finish
2008-10-01
Last updated by the study team
2017-05-16

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.